Stockscreener 앱 받기
81.09
1.40%
-1.15
시간 외 거래:
81.15
0.06
+0.07%
전일 마감가:
$82.24
열려 있는:
$81.68
하루 거래량:
2.13M
Relative Volume:
0.93
시가총액:
$12.84B
수익:
$4.34B
순이익/손실:
$-965.00M
주가수익비율:
-13.36
EPS:
-6.07
순현금흐름:
$869.00M
1주 성능:
+0.90%
1개월 성능:
+4.12%
6개월 성능:
-44.13%
1년 성능:
-22.24%
1일 변동 폭
$79.03
$81.90
1주일 범위
$79.03
$85.90
52주 변동 폭
$68.70
$156.66
일루미나 Stock (ILMN) Company Profile
명칭
Illumina Inc
전화
(858) 202-4500
주소
5200 ILLUMINA WAY, SAN DIEGO, CA
ILMN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
81.09 | 13.06B | 4.34B | -965.00M | 869.00M | -6.07 |
|
TMO
Thermo Fisher Scientific Inc
|
396.47 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.23 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
514.80 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.05 | 31.59B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
139.10 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
일루미나 Stock (ILMN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-04 | 재확인 | Citigroup | Neutral |
| 2025-02-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-02-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-02-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-11-12 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-10-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-08-28 | 업그레이드 | Argus | Hold → Buy |
| 2024-08-16 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-11 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-11-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 개시 | Bernstein | Underperform |
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-25 | 다운그레이드 | Argus | Buy → Hold |
| 2023-01-05 | 개시 | Scotiabank | Sector Perform |
| 2022-12-12 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-04 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-18 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-03-31 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 개시 | Barclays | Underweight |
| 2020-12-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-10-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-09-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-09-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-08-07 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-25 | 개시 | Guggenheim | Buy |
모두보기
일루미나 주식(ILMN)의 최신 뉴스
Gene Panel Market Projected to Witness Massive GrowthIllumina, Inc., Thermo Fisher Scientific - openPR.com
Illumina Inc (ILMN) Stock Price Down 3.31% on May 30 - GuruFocus
Genotyping Assay Market Deep Research Report Highlights Key AdvancementsIllumina, Thermo Fisher Scientific - openPR.com
Illumina’s PromoterAI unlocks rare disease clues in noncoding genome - statnews.com
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? - Yahoo Finance
Epigenetics Market Analysis 2025-2033: Advances in DNA - openPR.com
Illumina Inc.: Tackling Global Headwinds With Strategic Market Diversification! - Smartkarma
Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis - Insider Monkey
Illumina introduces PromoterAI for rare disease diagnosis By Investing.com - Investing.com Canada
Illumina introduces PromoterAI for rare disease diagnosis - Investing.com Australia
Operating a speedy, high-tech NGS lab in remote Australia - Illumina
Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - PR Newswire
Bioinformatics Market Detailed in New Research ReportThermo Fisher Scientific, Illumina - openPR.com
DNA giant Illumina spawned an ecosystem of competitors and customers - Endpoints News
Illumina widens access to cancer tests with Medicare and new CDx - Yahoo Finance
Patent Fight Breaks Out over Genetic Sequencing - Orthopedics This Week
Illumina at Bernstein Conference: Strategic Insights and Challenges - Investing.com
Transcript : Illumina, Inc. Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-28-2025 02 - marketscreener.com
Stifel Affirms Buy Rating on Illumina (ILMN) Stock - MSN
Illumina Expands Clinical Oncology Portfolio Unlocking New Standard of Care and Access to Precision Therapies - marketscreener.com
Illumina Expands Clinical Oncology Portfolio Unlocking New Standard Of Care And Access To Precision Therapies - marketscreener.com
Gene Expression Software Market Growth Projected at CAGR of 7.8% - openPR.com
Lab-on-a-chip and Microarrays (Biochip) Market Generated - openPR.com
Illumina expands oncology portfolio with new FDA-approved test By Investing.com - Investing.com Canada
Illumina expands oncology portfolio with new FDA-approved test - Investing.com
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies - PR Newswire
Stifel maintains Illumina stock buy rating, $135 target - Investing.com
Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain? - Yahoo Finance
Illumina at ESHG 2025 - Illumina
Video: How researchers are moving multiomics forward with Illumina technology - Illumina
GC Genome plans $30M IPO to diversify genomic products, suppliers - BioWorld MedTech
Microfluidic Market Is Booming Worldwide | Agilent Technologies, Inc., Illumina, Inc., Perkinelmer, Inc. - openPR.com
DNA Forensic Solution Market Size, Share & Trend, Regional - openPR.com
Single Cell Genome Sequencing Market to Witness Massive Growth - openPR.com
Illumina’s SWOT analysis: genetic giant’s stock faces China headwinds By Investing.com - Investing.com Nigeria
Illumina’s SWOT analysis: genetic giant’s stock faces China headwinds - Investing.com
Cell-Free DNA Isolation and Extraction Market - GlobeNewswire Inc.
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could BenefitInvesco QQQ Trust, Series 1 (NASDAQ:QQQ), Illumina (NASDAQ:IL - Benzinga
Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN) - Yahoo Finance
Tumor Profiling Market May Set New Growth Story | Illumina Inc., - openPR.com
Illumina Approves Key Proposals at Annual Meeting - TipRanks
Genotyping Market to Reach $61.6 Billion, Globally, by 2033 - openPR.com
Customized CRISPR for KJ, 10x and Illumina Lawsuits, Regeneron Bags 23andMe - Genetic Engineering and Biotechnology News
Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software - MSN
Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know - Yahoo Finance
Illumina Inc (ILMN) Stock Price Down 3.01% on May 21 - GuruFocus
miRNA Sequencing and Assays Market Research Report - GlobeNewswire
miRNA Sequencing and Assays Market Research Report 2025-2030 with Focus on 25+ Major Players Such as Abcam, HTG Molecular Diagnostics, Illumina, Lexogen, Meridian Bioscience - GlobeNewswire Inc.
Immune Repertoire Sequencing Market in 2025 Detailed Study - openPR.com
Spatial Genomics Transcriptomics Market Set to Witness - openPR.com
Bioinformatics Services Market Growth, Trends & Opportunities - openPR.com
일루미나 (ILMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
1.59%
자본화:
|
볼륨(24시간):